Integra LifeSciences Holdings (IART)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	1,486,360	1,506,670	1,533,950	1,298,690	1,461,480
Property, plant and equipment	US$ in thousands	340,199	311,302	311,703	287,529	337,404
Fixed asset turnover		4.37	4.84	4.92	4.52	4.33

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $1,486,360K ÷ $340,199K
= 4.37

The fixed asset turnover ratio for Integra Lifesciences Holdings Corp has fluctuated over the past five years. The ratio was 4.50 in 2019, increased to 4.77 in 2020, further improved to 4.95 in 2021, and peaked at 5.00 in 2022. However, there was a slight decline in 2023 to 4.53.

This ratio indicates that for every dollar invested in fixed assets, the company generated $4.53 of revenue in 2023. The trend suggests that the company has been effectively utilizing its fixed assets to generate sales, with a slight dip in 2023 compared to the previous year.

Overall, the company's ability to generate revenue from its fixed assets remains relatively strong, indicating efficient asset utilization and operational performance in converting investments in fixed assets into sales.